We are live on ! Find out more
TXMD icon

TherapeuticsMD
TXMD

43 hedge funds and large institutions have $7.73M invested in TherapeuticsMD in 2024 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 4

100% more call options, than puts

Call options by funds: $32K | Put options by funds: $16K

10% more funds holding

Funds holding: 39 → 43 (+4)

2% more capital invested

Capital invested by funds: $7.61M → $7.73M (+$120K)

0.06% less ownership

Funds ownership: 31.98% → 31.92% (-0.06%)

25% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 8

Holders
43
Holders Change
+4
Holders Change %
+10.26%
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
6
Reduced
8
Closed
4
Calls
$32K
Puts
$16K
Net Calls
+$16K
Net Calls Change
-$24K

Top Buyers

Rank Fund Capital Flow
1
CC
Clearline Capital
New York
+$160K
2
CHAM
Clear Harbor Asset Management
Connecticut
+$59.8K
3
PCG
Prosperity Consulting Group
Maryland
+$56.7K
4
Renaissance Technologies
Renaissance Technologies
New York
+$31.7K
5
UBS Group
UBS Group
Switzerland
+$15.1K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$305K
2
GF
Gabelli Funds
New York
-$39.4K
3
BCM
Bridgeway Capital Management
Texas
-$6.71K
4
A
AJOVista
Massachusetts
-$4.84K
5
BlackRock
BlackRock
New York
-$1.12K
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
26
Royal Bank of Canada
Ontario, Canada
$1K +$840 +363 +236%
US Bancorp
27
US Bancorp
Minnesota
$939 +$380 +164 +67%
Bank of America
28
Bank of America
North Carolina
$916 -$21 -9 -2%
JP Morgan Chase
29
JP Morgan Chase
New York
$671 – – –
Wells Fargo
30
Wells Fargo
California
$612 -$123 -53 -17%
RhumbLine Advisers
31
RhumbLine Advisers
Massachusetts
$320 – – –
PS
32
Principal Securities
Iowa
$289 – – –
HNB
33
Huntington National Bank
Ohio
$275 – – –
IA
34
IFP Advisors
Florida
$137 +$139 +60 New
OPTFSNA
35
Old Point Trust & Financial Services N A
Virginia
$115 +$116 +50 New
PWA
36
Provenance Wealth Advisors
Florida
$46 – – –
B
37
Birchbrook
Maine
$23 – – –
HI
38
Harbour Investments
Wisconsin
$18 – – –
GWMI
39
Guardian Wealth Management (Illinois)
Illinois
$5 – – –
Qube Research & Technologies (QRT)
40
Qube Research & Technologies (QRT)
United Kingdom
$5 – – –
APC
41
Aspire Private Capital
North Carolina
$2 – – –
AssetMark Inc
42
AssetMark Inc
California
$2 +$2 +1 New
EWA
43
EverSource Wealth Advisors
Alabama
$2 +$2 +1 New
A
44
AJOVista
Massachusetts
– -$4.84K -2,151 Closed
Barclays
45
Barclays
United Kingdom
– -$142 -63 Closed
FWM
46
Focused Wealth Management
New York
– -$36 -16 Closed
1
2

TXMD Hedge Fund Activity: Q1 2024 in Review

43 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in TherapeuticsMD (TXMD) for Q1 2024, worth a combined $7.73M — up 1.6% from $7.61M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new TXMD positions and 4 closed out — a net gain of 4 holders — while 6 added to existing stakes and 8 trimmed.

The largest buyer was Clearline Capital, adding an estimated $160K. The largest seller was Morgan Stanley, cutting an estimated $305K.

  • 43 institutional investors held TherapeuticsMD (TXMD) as of Q1 2024, up from 39 in Q4 2023.
  • Funds reported $7.73M of TherapeuticsMD stock for Q1 2024, up 1.6% quarter-over-quarter.
  • 8 funds opened new TherapeuticsMD positions in Q1 2024 and 4 closed out, a net change of +4 holders.
  • The largest TherapeuticsMD buyer in Q1 2024 was Clearline Capital, an estimated $160K added.
  • The largest TherapeuticsMD seller in Q1 2024 was Morgan Stanley, an estimated $305K sold.

Based on aggregated 13F filings for Q1 2024.